SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-007176
Filing Date
2023-03-10
Accepted
2023-03-10 08:30:43
Documents
16
Period of Report
2023-03-07
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 59087
2 ex3-1.htm EX-3.1 10068
3 ex3-2.htm EX-3.2 24889
4 ex99-1.htm EX-99.1 11090
5 ex99-1_001.jpg GRAPHIC 11178
  Complete submission text file 0001493152-23-007176.txt   314322

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lpcn-20230307.xsd EX-101.SCH 3227
7 XBRL LABEL FILE lpcn-20230307_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE lpcn-20230307_pre.xml EX-101.PRE 22359
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3718
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 23721710
SIC: 2834 Pharmaceutical Preparations